| |
|
|
Session 14
Oral Abstract Presentations Immune-Based Therapy Wednesday 10 - 11:15 am Auditorium |
| Moderators: | Thomas Harrer Univ of Erlangen, Germany and Cara Wilson Univ of Colorado Hlth Sci Ctr, Denver |
| 10:00 59 | Pegylated Interferon Alfa-2b: A New Therapeutic Option in the Treatment of Early-stage HIV Infection I. Schugt*, A. Kreuter, R. Schlottmann, A. Bader, P. Altmeyer, N. H. Brockmeyer St Josef-Hosp, Bochum, Nordrhein-Wetsfalen, Germany |
| 10:15 60 | Phase-I Study with a Therapeutic MVA-BN-Nef Vaccine in HIV-1 Infected Patients on HAART E. Harrer1, M. Bäuerle1, B. Ferstl1, P. Chaplin2, B. Petzold2, S. Bergmann1, M. Hamacher1, J. R. Kalden1, D. Willbold3, T. Harrer*1 1Univ of Erlangen, Germany; 2Bavarian Nordic GmbH, Munich, Germany; and 3Heinrich-Heine Univ, Res Ctr, Jülich, Germany |
| 10:30 61 | Therapeutic Vaccination with ALVAC-HIV vCP1433: A Recombinant Canarypox Vaccine in Chronically HIV-1 Infected Patients Treated with HAART: VACCITER (ANRS 094) R. Tubiana*1, G. Carcelain1, M. Vray1, K. Gourlain1, S.Hilpert1, C. Dalban1, A. Chermak1, R. El Habib2, M. Klein2, D. Costagliola1, V. Calvez1, B. Autran1, C. Katlama1, Vacciter Study Group3 1Pitié-Salpêtrière Hosp, Paris, France; 2Aventis Pasteur, Lyon, France; and 3Agence Natl de Res sur le SIDA, Paris, France |
| 10:45 62 | Immunological and Virological Efficacy of ALVAC-VIH 1433 and HIV Lipopeptides (Lipo-6T) Combined with SC IL-2 in Chronically HIV-infected Patients-Results of the ANRS 093 Randomized Study Y Levy*1, H Gahery-Segard2, C Durier3, A-S Lascaux1, V Meiffrédy3, C Goujard4, J-P Cassuto5, C Rouzioux6, R Elhabib7, J-G Guillet8, J-P Aboulker3, J-F Delfraissy4, ANRS 093 Study Group9 1Hosp Henri Mondor, Créteil; 2INSERM, U445, Paris; 3INSERM, SC10, Villejuif; 4Hosp Bicêtre, Kremlin-Bicêtre, France; 5Hosp Archet, Nice, France; 6Hosp Necker, Paris, France; 7Aventis Pasteur, Lyon, France; 8Hosp Cochin, Paris, France; and 9Agence Natl de Res sur le SIDA, Paris, France Paris, France |
| 11:00 63 | Differential Modulation of Whole Blood Naïve and Memory CD4+ and CD8+ T-cell Subsets by Viral Replication During Therapy Interruption in Chronically HIV-1 Infected Patients E. Papasavvas*1, B.Thiel1, M. Pistilli1, A. Mackiewicz1, M. Farabaugh1, E. C. Moore1, C. Gallo2, R. Gross3, A. Foulkes3, K. Mounzer2, L. Schmidt2, J. Ondercin2, J. Shull2, J. R. Kostman2, L. J. Montaner1 1Wistar Inst, Philadelphia, PA; 2Philadelphia Field Initiating Group for HIV-1 Trials, PA; and 3Ctr for Clin Epidemiology and Biostatistics and the Div of Infectious Diseases, Univ of Pennsylvania, Philadelphia, PA |